A Prolonged Multimodal Lateral Flow Immunoassay Enabled by Synergistic Peroxidase–Heme Nanohybrids
Analytical Chemistry · 11.08.2026 · 98 (31) · 22674-22686
DOI: 10.1021/acs.analchem.6c00014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 28.07.2026. Verfasst von Zixuan Ren und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing100871, P. R. Chi…. Hauptthemen laut MEDLINE: Heme, Troponin I. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Science and Technology Planning Project, National Key R&D Program of China.
Abstract (Originalsprache)
Horseradish peroxidase (HRP)-catalyzed lateral flow immunoassays (LFIAs) are powerful platforms for sensitive biosensing. However, the limited stability and short-lived catalytic activity of HRP significantly constrain their broader applications. Conventional HRP-based chemiluminescence (CL)-LFIAs typically emit for about 1 min before rapid decay, restricting signal capture. Herein, we report for the first time a prolonged CL/colorimetric LFIA enabled by β-cyclodextrin (β-CD)-functionalized polydopamine (PDA) nanospheres coloaded with HRP and heme, denoted β-CD-PDA/Heme/HRP (CPHH). This hybrid architecture integrates the complementary properties of both catalytic components: heme provides long-lasting but moderate CL, while HRP contributes strong yet transient luminescence. This synergistic interplay yields clearly enhanced and sustained signal output lasting up to 5 min on paper-based substrates, allowing sensitive and stable detection of cardiac troponin I (cTnI). When applied in an LFIA device, the CPHH probe can offer three readout modes, colorimetric (CM), enhanced colorimetric (ECM), and chemiluminescent (CL), covering a wide detection range of 0.1–500 ng/mL with limit of detection values of 10 ng/mL (CM), 0.47 ng/mL (ECM), and 0.95 ng/mL (CL). Further clinical research confirms its robustness and accuracy in real human samples. This work provides a new design paradigm for durable chemiluminescent nanoprobes and multifunctional LFIA systems for rapid and reliable cTnI detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing100871, P. R. China.
ORCID-Profile: Yue Cui
Förderung
- National Natural Science Foundation of China
- Beijing Science and Technology Planning Project
- National Key R&D Program of China
- State Key Laboratory of Vascular Homeostasis and Remodeling of Peking University
Zitieren
APA
Ren, Z., Chen, J., & Cui, Y. (2026). A Prolonged Multimodal Lateral Flow Immunoassay Enabled by Synergistic Peroxidase–Heme Nanohybrids. Analytical Chemistry, 98(31), 22674-22686. https://doi.org/10.1021/acs.analchem.6c00014
Vancouver
Ren Z, Chen J, Cui Y. A Prolonged Multimodal Lateral Flow Immunoassay Enabled by Synergistic Peroxidase–Heme Nanohybrids. Analytical Chemistry. 2026;98(31):22674-22686. doi:10.1021/acs.analchem.6c00014
BibTeX
@article{Ren2026,
author = {Ren, Zixuan and Chen, Jun and Cui, Yue},
title = {A Prolonged Multimodal Lateral Flow Immunoassay Enabled by Synergistic Peroxidase–Heme Nanohybrids},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {31},
pages = {22674--22686},
doi = {10.1021/acs.analchem.6c00014}
}
EUVIMED